
Keywords: Zika virus
![]() |
A Zika virus-responsive sensor-effector system in Aedes aegyptiS. Basu, C. M. Reitmayer, S. Lumley, B. Atkinson, M. L. Schade-Weskott, S. Rooney, W. Larner, E. E. Montiel, R. Gutierrez-Lopez, E. Levitt, H. M. Munyanduki, A. M. E. Elrefaey, A. T. Clarke, S. Koit, E. Zusinaite, R. Fragkoudis, A. Merits and L. Alphey, bioRxiv, 2023.02.06.527261. 2023.![]() Zika virus (ZIKV) is a recently re-emerged flavivirus transmitted primarily through the bite of an infected mosquito, Aedes aegypti being the main vector. ZIKV infection is associated with a range of adverse effects; infection during pregnancy can lead to foetal abnormalities, ... Keywords: Aedes aegypti, antiviral, arbovirus, Cas9, CRISPR, Gene drive, immunity, RNAi, siRNAs, transformation, transgenesis, vector, yellow-fever mosquito, Zika virus |
![]() |
A flavivirus-inducible gene expression system that modulates broad-spectrum antiviral activity against dengue and Zika virusesS.-C. Weng, Y.-X. Zhou and S.-H. Shiao, Insect Biochemistry and Molecular Biology, 142:103723. 2022.![]() Incidence of dengue virus (DENV) and Zika virus (ZIKV), two mosquito-borne flaviviruses, is increasing in large parts of the world. Vaccination and medication for these diseases are unsatisfactory. Here, we developed a novel antiviral approach, using a virus-inducible gene ... Keywords: Aedes aegypti, antiviral, arbovirus, Cas9, CRISPR, Gene drive, immunity, RNAi, siRNAs, transformation, transgenesis, vector, yellow-fever mosquito, Zika virus |
![]() |
The Antiviral Small-Interfering RNA Pathway Induces Zika Virus Resistance in Transgenic Aedes aegyptiA. E. Williams, I. Sanchez-Vargas, W. R. Reid, J. Y. Lin, A. W. E. Franz and K. E. Olson, Viruses, 12:18. 2020.![]() We used CRISPR/Cas9 to re-target a previously characterized locus (Chr2:321382225) and engineered mosquitoes expressing an inverted repeat (IR) dsRNA against the NS3/4A region of the ZIKV genome. Small RNA analysis revealed that the IR effector triggered the mosquito's siRNA ... Keywords: Aedes aegypti, antiviral, arbovirus, Cas9, CRISPR, Gene drive, immunity, RNAi, siRNAs, transformation, transgenesis, vector, yellow-fever mosquito, Zika virus |

Contact
David O’Brochta
Foundation for the
National Institutes of Health
geneconvenevi@fnih.org
RSS